[1]
Kazeminezhad, B. et al. 2014. Usefulness of insulin-like growth factor II mRNA-binding protein 3 (IMP3) as a new marker for the diagnosis of esophageal adenocarcinoma in challenging cases. Turkish Journal of Gastroenterology. 25, 3 (Jan. 2014), 253–256. DOI:https://doi.org/10.5152/tjg.2014.5454.